Evidence map›Paper›PMID 30610440›Full record

ArticleInternal and emergency medicine2019

Prevalence and outcome of diuretic resistance in heart failure.

Joan-Carles Trullàs, Jesús Casado, Jose-Luís Morales-Rull, Francesc Formiga, Alicia Conde-Martel, Raúl Quirós, Francisco Epelde, Álvaro González-Franco, Luis Manzano, Manuel Montero-Pérez-Barquero

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Internal and emergency medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01647932 (Safety and Efficacy of the Combination of Loop Diuretics With Thiazide-type Diuretics in Patients With Decompensated Heart Failure), which is not on this map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01647932 phase3completednot on this map

Safety and Efficacy of the Combination of Loop Diuretics With Thiazide-type Diuretics in Patients With Decompensated Heart Failure: a Double-blind, Randomized, Placebo-controlled Trial (CLOROTIC Trial).

TypeinterventionalSponsorSpanish Society of Internal MedicineRan2014 to 2019Enrolled232ConditionsHeart FailureArmshydrochlorothiazide, Placebo
3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 50 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Review
  10. Article
  11. Review
  12. Review
  13. Combinational Diuretics in Heart Failure.Current heart failure reports · 2024
    Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 10 institutions in 1 country.

Joan-Carles TrullàsInternal Medicine Service, Hospital de Olot, Av. Dels Països Catalans, 86, 17800, Olot, Girona, Spain. jctv5153@comg.cat.ORCID http://orcid.org/0000-0002-7380-3475
Jesús CasadoInternal Medicine Service, Hospital Universitario de Getafe, Madrid, Spain.
Jose-Luís Morales-RullInternal Medicine Service, Hospital Universitario "Arnau de Vilanova", Lleida, Spain.
Francesc FormigaInternal Medicine Service, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain.
Alicia Conde-MartelInternal Medicine Service, Hospital Universitario de Gran Canaria Dr. Negrín, Las Palmas, Spain.
Raúl QuirósInternal Medicine Service, Hospital Costa del Sol, Málaga, Spain.
Francisco EpeldeInternal Medicine Service, Corporaciò Sanitaria Parc Taulí, Barcelona, Spain.
Álvaro González-FrancoInternal Medicine Service, Hospital Universitario Central de Asturias, Asturias, Spain.
Luis ManzanoInternal Medicine Service, Hospital Universitario Ramón y Cajal, Universidad de Alcalá (IRYCIS), Madrid, Spain.
Manuel Montero-Pérez-BarqueroInternal Medicine Service, IMIBIC/Hospital Reina Sofía, Universidad de Córdoba, Córdoba, Spain.
Bellvitge University Hospital · ESCorporació Sanitària Parc Taulí · ESHospital Costa del Sol · ESHospital Universitari Arnau de Vilanova · ESHospital Universitario Central de Asturias · ESHospital Universitario de Getafe · ESHospital Universitario de Gran Canaria Doctor Negrín · ESInstituto Maimónides de Investigación Biomédica de Córdoba · ESUniversidad de Alcalá · ESUniversitat de Girona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diuretic resistance (DR) is common in patients with decompensated heart failure (HF), and is associated with adverse outcomes. To determine the prevalence of DR and its impact on survival among patients with decompensated HF, we prospectively evaluated the prevalence and influence on prognosis of DR (defined as persistent congestion despite ≥ 80 mg of furosemide per day) in a cohort of elderly patients from the Spanish HF registry (RICA) admitted for an acute decompensation of HF. Patients with new-onset HF were excluded. From the global cohort of 2067 patients, 435 (21%; 95% CI 19.3%-22.7%) patients met criteria for DR. Patients with DR had more comorbidities (hypercholesterolemia, diabetes mellitus, valvular disease, chronic kidney disease, and cancer) and a worse functional status compared to patients without DR. In addition, patients with DR had a higher proportion of ischemic etiology, more advanced functional class and lower left ventricular ejection fraction values. After 1 year of follow-up, all-cause mortality was higher in patients with DR with an adjusted hazard ratio of 1.37 (95% CI 1.06-1.79; p = 0.018). The prevalence of DR in a cohort of elderly patients admitted for acute HF decompensation is 21%. DR is an independent predictor of 1-year mortality.

Indexed as

PrevalenceAgedAnalysis of VarianceChi-Square DistributionDrug ResistanceFemaleFurosemideHeart FailureHumansLogistic ModelsMaleMiddle AgedPrognosisRegistriesRetrospective StudiesSodium Potassium Chloride Symporter InhibitorsFurosemideSodium Potassium Chloride Symporter InhibitorsDiureticsFurosemideHeart failure

Identifiers

PMID30610440
OpenAlexW2906702729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.